Skip to content

Clinical trials

Phase 2 Esophageal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 2 Country / region: China Clear all

137 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20091
20104
20114
20122
20131
20143
20157
20168
20174
20181
20197
20208
20218
20227
202319
202422
202520
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting47
Unknown status47
Completed23
Not yet recruiting11
Active, not recruiting5
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tianjin Medical University Cancer Institute and Hospital11
Cancer Institute and Hospital, Chinese Academy of Medical Sciences8
Fudan University8
Sun Yat-sen University7
Hangzhou Cancer Hospital6
Shanghai Chest Hospital6
Zhejiang Cancer Hospital6
The First Affiliated Hospital with Nanjing Medical University5
Zhejiang University5
Chinese Academy of Medical Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms137
Esophageal Squamous Cell Carcinoma32
Stomach Neoplasms9
Esophageal Diseases6
Carcinoma, Squamous Cell4
Digestive System Neoplasms4
Lung Neoplasms4
Neoplasms4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.

37 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.